Skip to main content

CORRECTION article

Front. Oncol., 09 January 2024
Sec. Genitourinary Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1216134

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

This article is a correction to:

  1. Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

    1. Read original article
Weifeng Wang&#x;Weifeng Wang1†Guankai Huang&#x;Guankai Huang1†Hansen Lin,&#x;Hansen Lin1,2†Lei Ren&#x;Lei Ren1†Liangmin Fu,*Liangmin Fu1,2*Xiaopeng Mao*Xiaopeng Mao1*
  • 1Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  • 2Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

A Corrigendum on
Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

By Wang W, Huang G, Lin H, Ren L, Fu L and Mao X (2023) Front. Oncol. 12:1102392. doi: 10.3389/fonc.2022.1102392

Incorrect Ethics No

In the published article, there was an error in Ethics No. Instead of “[2022]385”, it should be “[2022]574”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: proteomics, biology-informed analysis, CLIC1, prognosis, bladder cancer

Citation: Wang W, Huang G, Lin H, Ren L, Fu L and Mao X (2024) Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis. Front. Oncol. 13:1216134. doi: 10.3389/fonc.2023.1216134

Received: 19 June 2023; Accepted: 07 August 2023;
Published: 09 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Wang, Huang, Lin, Ren, Fu and Mao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiaopeng Mao, maoxp3@mail.sysu.edu.cn; Liangmin Fu, fulm3@mail2.sysu.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.